Publication | Closed Access

Low-dose Interleukin-2 Administered Pre-operatively to Patients with Gastric Cancer Activates Peripheral and Peritumoral Lymphocytes But Does Not Affect Prognosis

InflammationSurgical OncologyPeritumoral LymphocytesGastrointestinal OncologyMedicineImmunologyGastroenterologyPathologyUpper Gastrointestinal SurgeryImmunotherapyOncologyCancer Research